Publications by authors named "Debra L Bemis"

Claim this Profile
P
Perturbation biology nominates upstream-downstream drug combinations in RAF inhibitor resistant melanoma cells.
Anil Korkut, Weiqing Wang, Emek Demir, Bülent Arman Aksoy, Xiaohong Jing, Debra L Bemis

Elife· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
beta-carboline alkaloid-enriched extract from the amazonian rain forest tree pao pereira suppresses prostate cancer cells.
Debra L Bemis, Jillian L Capodice, Manisha Desai, Aaron E Katz, Ralph Buttyan

J Soc Integr Oncol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study on acupuncture for lower urinary tract symptoms related to chronic prostatitis/chronic pelvic pain.
Jillian L Capodice, Zhezhen Jin, Debra L Bemis, David Samadi, Brian A Stone

Chin Med· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dietary agents/supplements hit the clinic for prostate cancer chemoprevention.
Debra L Bemis, Ralph Buttyan

Discov Med· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trials of natural products as chemopreventive agents for prostate cancer.
Debra L Bemis, Aaron E Katz, Ralph Buttyan

Expert Opin Investig Drugs· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of herbal and over-the-counter dietary supplements for the prevention of prostate cancer.
Debra L Bemis, Jillian L Capodice, Jennifer E Costello, George C Vorys, Aaron E Katz

Curr Oncol Rep· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of herbal and over-the-counter dietary supplements for the prevention of prostate cancer.
Debra L Bemis, Jillian L Capodice, Jennifer E Costello, George C Vorys, Aaron E Katz

Curr Urol Rep· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zyflamend, a unique herbal preparation with nonselective COX inhibitory activity, induces apoptosis of prostate cancer cells that lack COX-2 expression.
Debra L Bemis, Jillian L Capodice, Aristotelis G Anastasiadis, Aaron E Katz, Ralph Buttyan

Nutr Cancer· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complementary and alternative medicine for chronic prostatitis/chronic pelvic pain syndrome.
Jillian L Capodice, Debra L Bemis, Ralph Buttyan, Steven A Kaplan, Aaron E Katz

Evid Based Complement Alternat Med· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A human- and male-specific protocadherin that acts through the wnt signaling pathway to induce neuroendocrine transdifferentiation of prostate cancer cells.
Xuezhen Yang, Min-Wei Chen, Stephane Terry, Francis Vacherot, Dominique K Chopin, Debra L Bemis

Cancer Res· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo.
Debra L Bemis, Jillian L Capodice, Manisha Desai, Ralph Buttyan, Aaron E Katz

Clin Cancer Res· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor cell hypoxia and the hypoxia-response signaling system as a target for prostate cancer therapy.
Aristotelis G Anastasiadis, Debra L Bemis, Brian C Stisser, Laurent Salomon, Mohamed A Ghafar

Curr Drug Targets· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis